[1] |
Wu XL, Ye ZJ, Xie X, Huang F, Kong DF, Feng TJ, et al
. Based on a Markov model, cost-effectiveness analysis of influenza vaccination among people aged 60 years and older in Shenzhen. Chin J Epidemiol
2022
;
43
(
7
):
1140
−
6
.
|
[2] |
Yang J, Atkins KE, Feng LZ, Baguelin M, Wu P, Yan H, et al
. Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis. BMC Med
2020
;
18
(
1
):
90
.
|
[3] |
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
. Technical guidelines for seasonal influenza vaccination in China (2023-2024). Chin J Epidemiol
2023
;
44
(
10
):
1507
−
30
.
|
[4] |
Wang YJ, Wang P, Zhang SD, Pan H
. Uncertainty modeling of a modified SEIR epidemic model for COVID-19. Biology (Basel)
2022
;
11
(
8
):
1157
.
|
[5] |
Bednarski S, Cowen LLE, Ma JL, Philippsen T, van den Driessche P, Wang MT
. A contact tracing SIR model for randomly mixed populations. J Biol Dyn
2022
;
16
(
1
):
859
−
79
.
|
[6] |
Zhao ZY, Zhou Y, Guan JX, Yan Y, Zhao J, Peng ZH, et al
. The relationship between compartment models and their stochastic counterparts: a comparative study with examples of the COVID-19 epidemic modeling. J Biomed Res
2024
;
38
(
2
):
175
−
88
.
|
[7] |
National Bureau of Statistics of China. China statistical yearbook 2023. Beijing: China Statistics Press. 2023. https://book.kongfz.com/434397/6853349509. (In Chinese).
|
[8] |
Yang J, Jit M, Zheng YM, Feng LZ, Liu XX, Wu JT, et al
. The impact of influenza on the health related quality of life in China: an EQ-5D survey. BMC Infect Dis
2017
;
17
(
1
):
686
.
|
[9] |
You XY, Zhang YL, Zeng JF, Wang CJ, Sun HP, Ma QH, et al
. Disparity of the Chinese elderly’s health-related quality of life between urban and rural areas: a mediation analysis. BMJ Open
2019
;
9
(
1
):
e024080
.
|
[10] |
Yang J, Jit M, Leung KS, Zheng YM, Feng LZ, Wang LP, et al
. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey. Infect Dis Poverty
2015
;
4
:
44
.
|
[11] |
Yue XM, Li YX, Wu JH, Guo JJ
. Current development and practice of pharmacoeconomic evaluation guidelines for universal health coverage in China. Value Health Reg Issues
2021
;
24
:
1
−
5
.
|
[12] |
Wang Q, Yue N, Zheng MY, Wang DL, Duan CX, Yu XG, et al
. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: a meta-analysis. Vaccine
2018
;
36
(
48
):
7262
−
9
.
|
[13] |
Molinari NAM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al
. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine
2007
;
25
(
27
):
5086
−
96
.
|
[14] |
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V
. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev
2018
;
2
(
2
):
CD004879
.
|
[15] |
Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C
. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev
2018
;
2
(
2
):
CD001269
.
|